Citigroup analyst Yigal Nochomovitz maintains Mirati Therapeutics (NASDAQ:MRTX) with a Buy and lowers the price target from $208 to $127.
Tesla, Apple, Ford, Southwest Airlines, Hoth Therapeutics: Why These Five Stocks Are Drawing Investors’ Attention Today?
Major Wall Street indices closed over 1% higher on Thursday after the much-awaited year-end rally materialized in the form of dip-buying. The Nasdaq Composite closed 2.59% higher while the S&P 500 rose 1.75%. The Dow gained 1.05%. Here are the five stocks that are drawing investors’ attention: